Exp Clin Endocrinol Diabetes 2010; 118(5): 333-337
DOI: 10.1055/s-0030-1248288
Article

© J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New York

Genetic Associations of IL1RN Polymorphisms with Metabolic Syndrome in a Korean Population

I.-H. Oh1 , C. Oh1 , H.-J. Kim2 , J.-M. Choi1 , T.-Y. Yoon1 , J.-H. Chung3 , B.-K. Choe1
  • 1Kyung Hee University, Department of Preventive Medicine, Seoul, Republic of Korea
  • 2Soonchunhyang University, College of Medicine, Chunan, Republic of Korea
  • 3Kyung Hee University, Kohwang Medical Research Institute, Seoul, Republic of Korea
Further Information

Publication History

received 29.09.2009 first decision 17.01.2010

accepted 22.01.2010

Publication Date:
08 March 2010 (online)

Abstract

Metabolic syndrome (MetS) is rapidly growing into one of the major public health issues worldwide. Interleukin 1 receptor antagonist (IL1Ra) functions as a competitor of proinflammatory cytokines and has an important role in metabolic functions, including insulin secretion. To identify the relationship between the interleukin 1 receptor antagonist gene(IL1RN) and MetS, we genotyped nine single nucleotide polymorphisms (SNPs) in the gene using direct sequencing in 66 MetS patients and 346 normal subjects in the Korean population. Among the nine polymorphisms, after adjusting for age and sex, rs928940 (G>T) showed a significant association with MetS in the codominant (P= 0.023) and recessive models (P= 0.011). Also, rs315952 (C>T) exhibited a significant association with MetS in the codominant model (P= 0.046). The results suggest that the IL1RN polymorphisms may be associated with MetS in the Korean population.

References

  • 1 Abrahamian H, Endler G, Exner M. et al . Association of low-grade inflammation with nephropathy in type 2 diabetic patients: Role of elevated CRP-levels and 2 different gene-polymorphisms of proinflammatory cytokines.  Exp Clin Endocrinol Diabetes. 2007;  115 38-41
  • 2 Al-Attar SA, Pollex RL, Ban MR. et al . Association between the FTO rs9939609 polymorphism and the metabolic syndrome in a non-caucasian multi-ethnic sample.  Cardiovasc Diabetol. 2008;  7 5
  • 3 Barrett J, Fry B, Maller J. et al . Haploview: Analysis and visualization of LD and haplotype maps.  Bioinformatics. 2005;  21 263-265
  • 4 Broeckel U, Hengstenberg C, Mayer B. et al . A locus on chromosome 10 influences C-reactive protein levels in two independent populations.  Hum Genet. 2007;  122 95-102
  • 5 Expert Panel on Detection, Evaluation, Treatment of High Blood Cholesterol in Adults . Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III).  JAMA. 2001;  285 2486-2497
  • 6 Expert Panel on Detection, Evaluation, Treatment of High Blood Cholesterol in Adults . Third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report.  Circulation. 2002;  106 3143-3421
  • 7 Grundy SM, Cleeman JI, Bairey Merz CN. et al . Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines.  J Am Coll Cardiol. 2004;  44 720-732
  • 8 Kempf K, Rose B, Illig T. et al . Vaspin (SERPINA12) genotypes and risk of type 2 diabetes: Results from the MONICA/KORA studies.  Exp Clin Endocrinol Diabetes. 2008;  112 157-170
  • 9 Lim S, Park KS, Lee HK. et al . Changes in the characteristics of metabolic syndrome in korea over the period 1998–2001 as determined by Korean national health and nutrition examination surveys.  Diabetes Care. 2005;  28 1810-1812
  • 10 Maggi S, Noale M, Zambon A. et al . Validity of the ATP III diagnostic criteria for the metabolic syndrome in an elderly Italian Caucasian population the Italian longitudinal study on aging.  Atherosclerosis. 2008;  197 877-882
  • 11 Malozowski S, Sahlroot JT, Mandrup-Poulsen T. et al . Interleukin-1-receptor antagonist in type 2 diabetes mellitus.  N Engl J Med. 2007;  356 1517– 1526
  • 12 Misra A, Wasir JS, Pandey RM. An evaluation of candidate definitions of the metabolic syndrome in adult Asian Indians.  Diabetes Care. 2005;  28 398-403
  • 13 Park H, Kim S, Lee J. et al . Prevalence and trends of metabolic syndrome in Korea: Korean national health and nutrition survey 1998–2001.  Diabetes Obes Metab. 2007;  9 50-58
  • 14 Peng Z, Hu P, Cui Y. et al . Interleukin (IL)-1beta, IL-1 receptor antagonist and IL-4 gene polymorphisms in ulcerative colitis in the chinese.  Zhonghua Nei Ke Za Zhi. 2002;  41 248-251
  • 15 Reiner AP, Wurfel MM, Lange LA. et al . Polymorphisms of the IL1-receptor antagonist gene (IL1RN) are associated with multiple markers of systemic inflammation.  Arterioscler Thromb Vasc Biol. 2008;  28 1407– 1412
  • 17 Saltevo J, Vanhala M, Kautiainen H. et al . Association of C-reactive protein, interleukin-1 receptor antagonist and adiponectin with the metabolic syndrome.  Mediators Inflamm. 2007;  2 93573
  • 16 Saltevo J, Vanhala M, Kautiainen H. et al . Gender differences in C-reactive protein, interleukin-1 receptor antagonist and adiponectin levels in the metabolic syndrome: A population-based study.  Diabetic Med. 2008;  25 747 750
  • 18 Solë X, Guino E, Valls J. et al . SNPStats: A web tool for the analysis of association studies.  Bioinformatics. 2006;  22 1928 1929
  • 19 Staiger H, Häring H. Adipocytokines: Fat-derived humoral mediators of metabolic homeostasis.  Exp Clin Endocrinol Diabetes. 2005;  113 67-79
  • 20 Strandberg L, Mellström D, Ljunggren Ö. et al . IL6 and IL1B polymorphisms are associated with fat mass in older men: The MrOS study sweden.  Obesity. 2008;  16 710-713
  • 21 Strandberg L, Lorentzon M, Hellqvist A. et al . Interleukin-1 system gene polymorphisms are associated with fat mass in young men.  J Clin Endocrinol Metab. 2006;  91 2749 2754
  • 22 Tarlow JK, Clay FE, Cork MJ. et al . Severity of alopecia areata is associated with a polymorphism in the interleukin-1 receptor antagonist gene.  J Invest Dermatol. 1994;  103 387-390
  • 23 Um JY, Lee KM, Kim HM. Polymorphism of interleukin-1 receptor antagonist gene and obesity.  Clinica Chimica Acta. 2004;  340 173-177
  • 24 Wong ND, Sciammarella MG, Polk D. et al . The metabolic syndrome, diabetes, and subclinical atherosclerosis assessed by coronary calcium.  J Am Coll Cardiol. 2003;  41 1547-1553
  • 25 World Medical Association . 2008-last update, World Medical Association Declaration of Helsinki – ethical principles for medical research involving human subjects.  Available: http://www.wma.net/en/30publications/10policies/b3/index.html 2008; 

Correspondence

Prof. B.-K. ChoeMD, PhD 

Kyung Hee University

Department of Preventive Medicine

1 Heogi-dong

Dongdaemun-gu

130-701 Seoul

Republic of Korea

Phone: 82-2-961-0318

Fax: 82-2-969-0792

Email: bebetter@khu.ac.kr

    >